Kang, Y., George, S., Jones, R. L., Rutkowski, P., Shen, L., Mir, O., Patel, S., Zhou, Y., von Mehren, M., Hohenberger, P., Villalobos, V., Brahmi, M., Tap, W. D., Trent, J., Pantaleo, M. A., Schöffski, P., He, K., Hew, P., Newberry, K., Roche, M., Heinrich, M. C., & Bauer, S. (2021). avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. Journal of clinical oncology, 39(28), 3128–3139. http://access.bl.uk/ark:/81055/vdc_100150610394.0x00003a